Related Experiment Videos
Antimicrobial prophylaxis in the neutropenic host: lessons of the past and perspectives for the future
1Kuzell Institute for Arthritis and Infectious Diseases, San Francisco, California 94115-1896.
Abstract:
Most attempts at preventing infection in neutropenic hosts have involved isolation of the patient from potential disease-causing microbes and the use of prophylatic antibiotics. Laminar airflow units were an expensive approach and the principal benefit may well have come from simultaneously administered regimens that suppressed the gut flora. The relationship between colonization of the gut by organisms that can subsequently cause systemic disease and gram-negative bacteremia has been supported by many observations, but the role of the normal anaerobic gastrointestinal flora in limiting overgrowth by potentially virulent gram-negative bacilli remains controversial. Cotrimoxazole has been a popular agent for prophylaxis but has serious deficiencies including lack of activity against Pseudomonas aeruginosa. Emergence of bacterial resistance to cotrimoxazole is an increasing problem. At present, the new fluoroquinolones offer promise as active agents against most gram-negative and some gram-positive pathogens but these agents lack anti-pneumocystis activity. It is widely perceived that improvements in clinical study design are needed in order to critically evaluate new developments in the field of antibiotic prophylaxis.
Insights
Preventing infections in neutropenic patients often involves isolation and prophylactic antibiotics. Current options like cotrimoxazole have limitations, while fluoroquinolones show promise but lack anti-pneumocystis activity, necessitating better study designs.
Area of Science:
- Infectious Diseases
- Hematology
- Pharmacology
Background:
- Neutropenic hosts are highly susceptible to infections.
- Traditional infection prevention includes isolation and prophylactic antibiotics.
- The role of gut flora in preventing gram-negative infections is debated.
Purpose of the Study:
- To review current strategies for infection prevention in neutropenic patients.
- To evaluate the efficacy and limitations of prophylactic antibiotics.
- To discuss emerging antibiotic options and the need for improved clinical trial design.
Main Methods:
- Literature review of infection prevention strategies in neutropenic hosts.
- Analysis of the effectiveness and drawbacks of prophylactic antibiotics.
- Discussion of the role of gut microbiota and antibiotic resistance.
Main Results:
- Isolation and prophylactic antibiotics are common but have limitations.
- Cotrimoxazole is effective against some pathogens but lacks activity against Pseudomonas aeruginosa and faces resistance issues.
- Fluoroquinolones are active against many gram-negative and some gram-positive pathogens but not Pneumocystis.
Conclusions:
- Existing antibiotic prophylaxis methods have significant deficiencies.
- Newer agents like fluoroquinolones offer potential but have specific limitations.
- Improved clinical study designs are crucial for evaluating new antibiotic prophylaxis strategies.